TABLE 1.
Baseline Characteristics
| Variables | All Patients (n = 136) | Developed Hypertriglyceridemia (n = 38) | Did Not Develop Hypertriglyceridemia (n = 98) | pc |
|---|---|---|---|---|
| Age (yr)a | 62 (54–72) | 57 (47.5–65.8) | 65 (57.3–73) | 0.0007 |
| Male, n (%) | 87 (63.9) | 22 (57.9) | 63 (64.3) | 0.759 |
| Weight (kg)a | 80.3 (70.2–97) | 77.8 (70.1–97.8) | 82 (70.3–96) | 0.7562 |
| Height (cm)a | 172 (163.8–180) | 168 (163.3–172.9) | 174 (165–180) | 0.0506 |
| Body mass index (kg/m2)a | 28.4 (24–2) | 28.5 (25–31.9) | 28 (23.9–31.8) | 0.3037 |
| Ethnicity, n (%) | ||||
| White | 85 (62) | 19 (50) | 66 (67.3) | 0.429 |
| African American | 13 (9.5) | 4 (10.5) | 9 (9.2) | 0.759 |
| Asian | 6 (4.4) | 1 (2.6) | 5 (5.1) | 1.00 |
| Hispanic | 10 (7.3) | 4 (10.5) | 6 (6.1) | 0.474 |
| Not reported | 19 (13.9) | 7 (18.4) | 12 (12.2) | 0.428 |
| Other | 3 (2.2) | 3 (7.9) | 0 | 0.024 |
| Comorbidities, n (%) | ||||
| Cardiovascular diseaseb | 96 (70.1) | 22 (57.9) | 74 (75.5) | 0.043 |
| Diabetes | 44 (32.1) | 10 (26.3) | 34 (13.3) | 0.349 |
| Chronic kidney disease, end-stage renal disease, or hemodialysis | 16 (11.7) | 3 (7.9) | 13 (13.3) | 0.556 |
| Acute kidney injury | 27 (19.7) | 11 (28.9) | 16 (16.3) | 0.048 |
| Hypothyroidism | 17 (12.4) | 4 (10.5) | 13 (13.3) | 0.779 |
| Alcohol Abuse | 20 (14.6) | 6 (15.8) | 14 (14.3) | 0.824 |
| Lupus | 2 (1.5) | 0 | 2 (2) | 0.629 |
| Bone marrow transplant | 3 (2.2) | 3 (7.9) | 0 | 0.021 |
| None | 17 (12.4) | 5 (13.2) | 12 (12.2) | 0.885 |
| Not assessed | 3 (2.2) | 1 (2.6) | 2 (2) | 0.833 |
| Acute Physiology and Chronic Health Evaluation II scorea | 18 (13–23.3) | 22 (15–25) | 18 (12–23) | 0.030 |
| Medical ICU, n (%) | 106 (77.9) | 31 (81.6) | 75 (76.5) | 0.299 |
| Surgical ICU, n (%) | 30 (22.1) | 7 (18.4) | 23 (23.5) | 0.258 |
| Neurosurgical | 9 (30) | 3 (42.9) | 6 (26.1) | 0.404 |
| Cardiothoracic | 8 (26.7) | 2 (28.6) | 6 (26.1) | 0.898 |
| General | 13 (43.3) | 2 (28.6) | 11 (47.8) | 0.378 |
| Baseline triglyceride levela | 84 (70–104.8) | 87 (74–104.8) | 83.5 (68.8–104.8) | 0.497 |
aData presented as median (interquartile range).
bCardiovascular disease: hypertension, coronary artery disease, heart failure, acute coronary syndrome, stroke, arrhythmia.
cComparison between patients who developed hypertriglyceridemia and those who did not.